Pfizer Inc. (PFE)
28.52
-0.30
(-1.02%)
USD |
NYSE |
Sep 04, 13:58
Pfizer Cash and Short Term Investments (Annual) : 13.60B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 13.60B |
| December 31, 2024 | 20.48B |
| December 31, 2023 | 12.69B |
| December 31, 2022 | 22.73B |
| December 31, 2021 | 31.07B |
| December 31, 2020 | 12.22B |
| December 31, 2019 | 9.646B |
| December 31, 2018 | 18.83B |
| December 31, 2017 | 20.01B |
| December 31, 2016 | 17.85B |
| December 31, 2015 | 23.29B |
| December 31, 2014 | 36.12B |
| December 31, 2013 | 32.41B |
| December 31, 2012 | 32.40B |
| December 31, 2011 | 26.76B |
| December 31, 2010 | 28.01B |
| December 31, 2009 | 25.97B |
| December 31, 2008 | 23.73B |
| December 31, 2007 | 25.48B |
| December 31, 2006 | 27.71B |
| December 31, 2005 | 22.23B |
| December 31, 2004 | 19.89B |
| December 31, 2003 | 11.95B |
| Date | Value |
|---|---|
| December 31, 2002 | 12.55B |
| December 31, 2001 | 8.615B |
| December 31, 2000 | 6.863B |
| December 31, 1999 | 4.442B |
| December 31, 1998 | 3.929B |
| December 31, 1997 | 1.589B |
| December 31, 1996 | 1.637B |
| December 31, 1995 | 1.512B |
| December 31, 1994 | 2.019B |
| December 31, 1993 | 1.176B |
| December 31, 1992 | 1.704B |
| December 31, 1991 | 1.901B |
| December 31, 1990 | 1.068B |
| December 31, 1989 | 1.058B |
| December 31, 1988 | 807.50M |
| December 31, 1987 | 1.031B |
| December 31, 1986 | 398.60M |
| December 31, 1985 | 412.60M |
| December 31, 1984 | 880.90M |
| December 31, 1983 | 715.70M |
| December 31, 1982 | 611.20M |
| December 31, 1981 | 566.90M |
| December 31, 1980 | 490.60M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Johnson & Johnson | 20.10B |
| Eli Lilly & Co. | 7.268B |
| Merck & Co., Inc. | 14.69B |
| Bristol Myers Squibb Co. | 10.67B |
| Viatris, Inc. | 1.454B |